Issue of new ordinary shares

RNS Number : 3606J

The MedicX Fund Limited

15 July 2013

 



For immediate release

15 July 2013

MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")

Issue of new ordinary shares

MedicX Fund Limited announces that earlier today it issued for cash, subject to listing, 3,700,000 new ordinary shares of no par value in the Company (the "New Shares").  The issue price per New Share (before expenses) was 78 pence.

Application has been made for the New Shares to be admitted to the premium segment of the Official List and to trading on the Main Market of the London Stock Exchange.  It is expected that dealings in the New Shares will commence at 8.00 a.m. on 18 July 2013 ("Admission"). 

Total Voting Rights

In accordance with the Financial Conduct Authority's Disclosure and Transparency Rules, the total number of ordinary shares in the capital of the Company in issue on Admission will be 268,971,497 (excluding treasury shares) each with one voting right. 

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company, under the Disclosure and Transparency Rules. 

The Company also holds 1,974,283 ordinary shares in treasury. 

- End -

For further information please contact:

MedicX Group                                                                [phone]

Keith Maddin, Chairman

Mike Adams, Chief Executive Officer

Mark Osmond, Chief Financial Officer

MedicX Fund Limited                                                       [phone]

David Staples, Chairman

Canaccord Genuity Limited                                              [phone]

Andrew Zychowski / Lucy Lewis  

Buchanan                                                                      [phone]

Charles Ryland / Sophie McNulty

Information on MedicX Fund Limited

MedicX Fund Limited ("MXF", the "Fund" or the "Company", or together with its subsidiaries, the "Group") the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange in November 2006.  It has committed investment of £449.7 million and a portfolio of 122 properties.

The Investment Adviser to the Company is MedicX Adviser Ltd, which is authorised and regulated by the Financial Conduct Authority and is a subsidiary of the MedicX Group.  The MedicX Group is a specialist investor, developer and manager of healthcare properties with 29 people operating across the UK. 

The Company's website address is www.medicxfund.com. Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website), nor the contents of any website accessible from hyperlinks within this announcement, are incorporated into, or forms part of, this announcement.

 

END

 

 

IOEKMGMNDKMGFZM